{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:55:49Z","timestamp":1791143749143,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1093\/brain\/awt067","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T23:11:27Z","timestamp":1364598687000},"page":"1568-1577","source":"Crossref","is-referenced-by-count":259,"title":["Parkinsonian apathy responds to dopaminergic stimulation of D2\/D3 receptors with piribedil"],"prefix":"10.1093","volume":"136","author":[{"given":"St\u00e9phane","family":"Thobois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Lhomm\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Ardouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Castrioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Fraix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pelissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Chabardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Bosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Krack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,29]]},"reference":[{"key":"key\n\t\t\t\t20170330121316_awt067-B1","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptoms in Parkinson's disease","volume":"24","author":"Aarsland","year":"2009","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170330121316_awt067-B2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","article-title":"Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease","volume":"165","author":"Ardouin","year":"2009","journal-title":"Rev Neurol (Paris)"},{"key":"key\n\t\t\t\t20170330121316_awt067-B3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.23872","article-title":"Impact of apathy on health-related quality of life in recently diagnosed Parkinson\u2019s diseae: the ANIMO study","volume":"27","author":"Benito-Leon","year":"2012","journal-title":"Mov Disord"},{"issue":"Pt 9","key":"key\n\t\t\t\t20170330121316_awt067-B7","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/brain\/awp094","article-title":"Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients","volume":"132","author":"B\u00f3di","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170330121316_awt067-B8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.20750","article-title":"The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg\/day) with bromocriptine (25 mg\/day) in early combination with levodopa in Parkinson's disease","volume":"21","author":"Castro-Caldas","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170330121316_awt067-B9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.21949","article-title":"Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom","volume":"23","author":"Czernecki","year":"2008","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170330121316_awt067-B11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"A randomized trial of deep-brain stimulation for Parkinson's disease","volume":"355","author":"Deuschl","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170330121316_awt067-B46","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1212\/WNL.0b013e3182698dd4","article-title":"Apathy in Parkinson's disease: what are the underlying mechanisms","volume":"79","author":"Dujardin","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170330121316_awt067-B12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2011.07.002","article-title":"Is depression in Parkinson's disease (PD) a specific entity?","volume":"139","author":"Even","year":"2012","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20170330121316_awt067-B13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170330121316_awt067-B14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jnnp.2002.009803","article-title":"Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease","volume":"75","author":"Funkiewiez","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nbd.2011.12.041","article-title":"Psychosis, apathy, depression and anxiety in Parkinson's disease","volume":"46","author":"Gallagher","year":"2012","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170330121316_awt067-B16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B17","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa035275","article-title":"Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"349","author":"Krack","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170330121316_awt067-B18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinthera.2009.01.012","article-title":"The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies","volume":"31","author":"Leentjens","year":"2009","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170330121316_awt067-B19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/jnp.17.2.214","article-title":"Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole","volume":"17","author":"Lemke","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20170330121316_awt067-B20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"issue":"Pt 5","key":"key\n\t\t\t\t20170330121316_awt067-B21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours","volume":"135","author":"Lhomm\u00e9e","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170330121316_awt067-B22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170330121316_awt067-B23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2010.06.002","article-title":"From the cell to the clinic: a comparative review of the partial D2\/D3receptor agonist and \u03b12-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease","volume":"128","author":"Millan","year":"2010","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20170330121316_awt067-B24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(12)70106-0","article-title":"Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial","volume":"11","author":"Moreau","year":"2012","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1474-4422(12)70264-8","article-title":"Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial","volume":"12","author":"Odekerken","year":"2013","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.73.6.636","article-title":"Apathy in Parkinson's disease","volume":"73","author":"Pluck","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp-2012-302684","article-title":"Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic","volume":"84","author":"Pondal","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1978.01770290091008","article-title":"Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response","volume":"35","author":"Post","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B30","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/mds.21122","article-title":"Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study","volume":"21","author":"Rascol","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170330121316_awt067-B31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.22922","article-title":"Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study","volume":"25","author":"Rascol","year":"2010","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170330121316_awt067-B32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0b013e31815d25ce","article-title":"Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study","volume":"31","author":"Rektorova","year":"2008","journal-title":"Clin Neuropharmacol"},{"issue":"Pt 6","key":"key\n\t\t\t\t20170330121316_awt067-B33","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170330121316_awt067-B34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/gps.755","article-title":"The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment","volume":"17","author":"Robert","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B35","first-page":"441","volume-title":"Clinical epidemiology. A basic science for clinical medicine","author":"Sackett","year":"1991","edition":"2ns edn"},{"key":"key\n\t\t\t\t20170330121316_awt067-B36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of hedonic tone: the Snaith-Hamilton pleasure scale","volume":"167","author":"Snaith","year":"1995","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20170330121316_awt067-B38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152706784111551","article-title":"The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders","volume":"5","author":"Sokoloff","year":"2006","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"key\n\t\t\t\t20170330121316_awt067-B39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson's disease","volume":"4","author":"Starkstein","year":"1992","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20170330121316_awt067-B40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.24061","article-title":"Apathy in Parkinson's disease: diagnostic and etiological dilemmas","volume":"27","author":"Starkstein","year":"2012","journal-title":"Mov Disord"},{"issue":"Pt 4","key":"key\n\t\t\t\t20170330121316_awt067-B41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170330121316_awt067-B42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Pt 10","key":"key\n\t\t\t\t20170330121316_awt067-B43","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/brain\/awn214","article-title":"A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease","volume":"131","author":"Voon","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170330121316_awt067-B44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(08)70114-5","article-title":"Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study","volume":"7","author":"Witt","year":"2008","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170330121316_awt067-B45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/136\/5\/1568\/11138271\/awt067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:11:06Z","timestamp":1562843466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awt067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,29]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,3,29]]},"published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awt067","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995905.793476143","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995905.793476627","asserted-by":"object"}]},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,29]]}}}